AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
we communicated our ambition to deliver 20 new medicines by 2030 and I'm pleased to report that we have eight new medicines approved to date, including the recent approval of Datroway, which was previously called Dato-DXD earlier
Total R&D spending was $3.5 billion. The corporate headquarters are in London, England, the research and development (R&D) headquarters are in Södertälje, Sweden. Major R&D centres are located on three continents in the United States, United Kingdom, Sweden, and India. ...